Delivery Order SPE2DB24D2212-SPE2DB24FHNNJ

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 8 mg tablets. The contract has a firm fixed price of $1,271.26 and an ultimate completion date of October 9, 2024. This is a delivery order contract, which is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a $7,854.60 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 4,565,502,316 units of Ondansetron ODT 4 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to AmerisourceBergen Drug Corporation, a large pharmaceutical distributor. The $6,647.82 firm-fixed-price delivery order is for the supply of 4559469543 Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a performance period through December 30, 2022. This award is a part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,751,394 units of Ondansetron ODT 4 mg tablets. The contract has a firm fixed price of $5,976.49 and a completion date of September 11, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,387.14 firm fixed-price delivery order is for 4,567,105,161 units of the medication Ondansetron ODT 4 mg Tablet 30s, with a performance period through January 31, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, worth $1,440.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,689,323 units of Ondansetron ODT 4 mg tablets in 30-count packs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,811,993 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $8,982.21 firm-fixed-price delivery order contract has an ultimate completion date of December 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award, valued at $2,068.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,598,427 units of the medication Ondansetron ODT 8 mg Tablet, with a completion date of December 4, 2024. The contract is structured as a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, with a total ceiling value of $6,568.58 and a period of performance ending on November 28, 2023. The contract is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,489.63 firm-fixed-price delivery order is for 4,567,052,683 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB24FHNNJ
    Delivery Order

The federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 30-count packets of the medication Ondansetron ODT 8 mg tablets. The definitive contract has a firm fixed price of $6,969.92 and a completion date of September 6, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/5/24, 10:00 AM